Drug-Eluting Stents
Research News and Information

Monday, November 23, 2009

Drug-eluting versus bare-metal stents for treating saphenous vein grafts.

29 Sep 2009 BACKGROUND: Current data show conflicting results regarding safety and efficacy of drug-eluting stents (DES) versus bare-metal stents (BMS) for treating saphenous vein grafts (SVG). Our objective was to compare DES with BMS for SVG intervention. ... Read more...

Drug-eluting stents: a study of international practice.

29 Sep 2009 OBJECTIVE: We aimed to analyze trends in drug-eluting stents (DES) use in four international health care and regulatory settings. BACKGROUND: Accounts suggest a differential approach to DES internationally and recent reductions in use following ... Read more...

Design and rationale of the TRI-stent adjudication study (TRIAS) program.

29 Sep 2009 BACKGROUND: In the treatment of coronary artery disease, a "pro-healing" approach for prevention of in-stent restenosis and late stent thrombosis is intuitively favored over the use of cytotoxic or cytostatic drugs released from a drug-eluting stent ... Read more...

Latest indexed articles for 'Drug-Eluting Stents'

These are the very latest articles for this heading:

• Drug-eluting versus bare-metal stents for treating saphenous vein grafts. 29 Sep 2009
• Drug-eluting stents: a study of international practice. 29 Sep 2009
• Design and rationale of the TRI-stent adjudication study (TRIAS) program. 29 Sep 2009
• Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. 29 Sep 2009
• Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. 26 Sep 2009
• Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study). 20 Sep 2009
• Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. 19 Sep 2009
• New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries. 6 Sep 2009
• Definition, incidence, correlates, and clinical impact of "nuisance" bleeding in patients undergoing drug-eluting stent implantation. 5 Sep 2009
• Simultaneous right and left coronary occlusion caused by an extensive dissection to the coronary sinus of Valsalva during percutaneous intervention in right coronary artery. 30 Aug 2009
• Three-year prognosis of Japanese patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents. 30 Aug 2009
• Importance of creativity: new applications of the Proxis catheter. 30 Aug 2009
• Novel uses of the Proxis embolic protection catheter. 30 Aug 2009
• Re: Non-cardiac surgery and antiplatelet therapy following coronary artery stenting. 30 Aug 2009
• Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation. 30 Aug 2009
• 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. 30 Aug 2009
• Invited commentary. 30 Aug 2009
• Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia. 30 Aug 2009
• The final score: use of a sculpting balloon. 30 Aug 2009
• Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. 29 Aug 2009

See a longer list of these articles.

Technical information about 'Drug-Eluting Stents'

Definition: Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.

Descriptor UI: D054855

Alternative terms: Drug-Eluting Stents; Drug Eluting Stents; Drug-Eluting Stent; Stent, Drug-Eluting; Stents, Drug-Eluting; Stents, Drug Eluting; Drug-Coated Stents; Drug Coated Stents; Drug-Coated Stent; Stent, Drug-Coated; Stents, Drug-Coated; Stents, Drug Coated;

Allowable Qualifiers: adverse effects; classification; economics; history; microbiology; parasitology; standards; supply & distribution; trends; utilization; veterinary; statistics & numerical data; contraindications; virology; ethics; psychology;

Tree Number: E07.695.750.500;

History Note: 2008